Review article · 2024 · Open access
Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update
Journal of Clinical Medicine, 13(18), 5637 · Published 23 September 2024 · DOI 10.3390/jcm13185637
In brief
“Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update” is a 2024 review article by Eva-Maria Tsapakis and 6 co-authors, published in Journal of Clinical Medicine. OpenAlex counts 20 citations as of 20 November 2026, which puts it in the top 2% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Clinical Medicine.
- Citations
- 20
- Most cited in
- 2026 (12)
- Field-weighted impact
- 0.94
- References
- 159
- Authors
- 7
Abstract
Schizophrenia is a chronic psychotic disorder comprising positive symptoms, negative symptoms, and cognitive deficits. Negative symptoms are associated with stigma, worse functional outcomes, and a significant deterioration in quality of life. Clinical diagnosis is challenging despite its significance, and current treatments offer little improvement in the burden of negative symptoms. This article reviews current pharmacological strategies for treating negative symptoms. Dopaminergic, glutamatergic, serotonergic, noradrenergic, cholinergic, anti-inflammatory compounds, hormones, and psychostimulants are explored. Finally, we review pharmacological global treatment guidelines for negative symptoms. In general, switching to a second-generation antipsychotic seems to be most often recommended for patients with schizophrenia on first-generation antipsychotics, and an add-on antidepressant is considered when depression is also present. However, the treatment of negative symptoms remains an unmet need. Future, larger clinical studies and meta-analyses are needed to establish effective pharmacological agents for the effective treatment of negative symptoms.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Tsapakis, E.-M., Treiber, M., Mitkani, C. A., Drakaki, Z., Cholevas, A., Spanaki, C., & Fountoulakis, K. Ν. (2024). Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update. Journal of Clinical Medicine, 13(18), 5637. https://doi.org/10.3390/jcm13185637
MLA 9
Tsapakis, Eva-Maria, et al. “Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update.” Journal of Clinical Medicine, vol. 13, no. 18, 2024, p. 5637. https://doi.org/10.3390/jcm13185637.
Chicago
Tsapakis, Eva-Maria, Michael Treiber, Calypso A. Mitkani, Zoe Drakaki, Anastasios Cholevas, Cleanthe Spanaki, and Konstantinos Ν. Fountoulakis. 2024. “Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update.” Journal of Clinical Medicine 13 (18): 5637. https://doi.org/10.3390/jcm13185637.
Harvard
Tsapakis, E.-M. et al. (2024) ‘Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update’, Journal of Clinical Medicine, 13(18), p. 5637. doi:10.3390/jcm13185637.
IEEE
E.-M. Tsapakis et al., “Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update,” Journal of Clinical Medicine, vol. 13, no. 18, p. 5637, 2024, doi: 10.3390/jcm13185637.
BibTeX
@article{tsapakis2024pharmacological,
title = {{Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update}},
author = {Tsapakis, Eva-Maria and Treiber, Michael and Mitkani, Calypso A. and Drakaki, Zoe and Cholevas, Anastasios and Spanaki, Cleanthe and Fountoulakis, Konstantinos Ν.},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {18},
pages = {5637},
doi = {10.3390/jcm13185637},
url = {https://doi.org/10.3390/jcm13185637}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- schizophrenia
- negative symptoms
- pharmacotherapy
- atypical antipsychotics
- typical antipsychotics
- depression
- dopaminergic agents
- glutamatergic agents
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Tsapakis, E.-M., Treiber, M., Mitkani, C. A., Drakaki, Z., Cholevas, A., Spanaki, C., & Fountoulakis, K. Ν. (2024). Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update. Journal of Clinical Medicine, 13(18), 5637. https://doi.org/10.3390/jcm13185637
How many times has this paper been cited?
20 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Clinical Medicine: sign in and open the PDF from this page.
Who wrote this paper?
Eva-Maria Tsapakis, Michael Treiber, Calypso A. Mitkani, Zoe Drakaki, Anastasios Cholevas, Cleanthe Spanaki, Konstantinos Ν. Fountoulakis.
What is the DOI of this paper?
10.3390/jcm13185637, permanently at https://doi.org/10.3390/jcm13185637. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.